1
/
of
1
OHCORE
Tirzepatide /替尔泊肽
Tirzepatide /替尔泊肽
Main Function & Mechanism
GLP-1/GIP dual receptor agonist; suppresses appetite, lowers blood sugar, induces weight loss
Administration:
Subcutaneous injection; starting dose 2.5mg/week, maximum 15mg/week
Provide logistics services
Share
